Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 30/08/22 → 1/06/24 |
Clinical Trial Phase
- Phase I
A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumor Activity of BGB-B167, Alone and in Combination With Tislelizumab in Patients With Selected Advanced or Metastatic Solid Tumors
- Ameratunga, Malaka (Primary Chief Investigator (PCI))
- Brooks, Christine (Project Manager)
Project: Research